Genevieve M. Razick

Genevieve focuses her practice on advising life sciences companies on a broad range of regulatory matters including  advertising and promotion issues for compliance with FDA and FTC requirements, as well as conducting regulatory due diligence as it relates to the sale, acquisition and restructuring of FDA-regulated entities. Genevieve advises pharmaceutical and medical device companies on Sunshine Act reporting, PhRMA and AdvaMed Code compliance, and fraud and abuse risks for proposed arrangements involving remuneration under the Federal Anti-Kickback Statute. She also reviews formulary committee and advisory board materials for pharmaceutical companies for compliance with FDA and Anti-Kickback Statute regulatory requirements.

Prior to joining Baker McKenzie, Genevieve practiced food and drug law at law firms in both DC and Atlanta.

• Order of the Coif
• ABA/BNA Award for Excellence in the Study of Health Law, CALI Awards in Health Law Finance & Delivery
• FDA Law, Law & Social Welfare, Genetics and the Law, Corporations, Property I, Property II, Contracts II, Civil Procedure II
• Named one of the "Top Authors" for Healthcare in JD Supra Readers’ Choice Awards, 2019